Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for ISRG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 28.46%
March 31, 2026 29.81%
December 31, 2025 27.89%
September 30, 2025 28.31%
June 30, 2025 27.22%
March 31, 2025 31.23%
December 31, 2024 28.51%
September 30, 2024 28.00%
June 30, 2024 26.44%
March 31, 2024 28.95%
December 31, 2023 31.67%
September 30, 2023 24.08%
June 30, 2023 24.26%
March 31, 2023 21.27%
December 31, 2022 20.34%
September 30, 2022 20.85%
June 30, 2022 20.60%
March 31, 2022 24.83%
December 31, 2021 24.68%
September 30, 2021 27.59%
June 30, 2021 35.72%
March 31, 2021 33.68%
December 31, 2020 27.36%
September 30, 2020 29.40%
June 30, 2020 8.24%
Date Value
March 31, 2020 28.76%
December 31, 2019 28.39%
September 30, 2019 35.34%
June 30, 2019 28.79%
March 31, 2019 31.22%
December 31, 2018 27.84%
September 30, 2018 31.69%
June 30, 2018 28.00%
March 31, 2018 33.90%
December 31, 2017 -3.53%
September 30, 2017 36.96%
June 30, 2017 29.39%
March 31, 2017 26.60%
December 31, 2016 27.03%
September 30, 2016 30.83%
June 30, 2016 27.50%
March 31, 2016 22.98%
December 31, 2015 28.17%
September 30, 2015 28.40%
June 30, 2015 22.95%
March 31, 2015 18.23%
December 31, 2014 24.28%
September 30, 2014 22.49%
June 30, 2014 20.30%
March 31, 2014 9.53%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Stryker Corp. 19.37%
Zimmer Biomet Holdings, Inc. 9.17%
Abbott Laboratories 7.37%
Boston Scientific Corp. 16.63%
Globus Medical, Inc. 19.20%